In a major breakthrough for cancer treatment, Russia’s mRNA-based vaccine Enteromix has demonstrated 100% efficacy and safety during clinical trials, according to the Federal Medical and Biological Agency (FMBA). Experts say the development could change the future of oncology, offering a new ray of hope for patients worldwide. A New…
